Therapeutic Area Scientific Communications Lead (Director)

Today, Pfizer Oncology has an industry-leading portfolio of 25 approved innovative cancer medicines, including major therapies for metastatic breast cancer, prostate cancer, urothelial carcinoma and haemato-oncological malignancies. Pfizer’s in-line portfolio is focused on four broad, key areas: breast cancer, genitourinary cancer, hematology and precision medicine, complemented by an extensive pipeline of over 50 programs in clinical development.

ROLE SUMMARY

• The Therapeutic Area (TA) Scientific Communications Lead will report to the Head of Medical Strategy Management in Pfizer Oncology Medical.
• The role will serve as a key interface between Oncology Medical and Development TA teams, US and International Field Medical teams and Pfizer U.S. (Medical Platforms) to ensure that overall scientific communication and content strategy and channel-specific communication strategies reflect TA priorities and that tactical execution of medical and scientific communication activities occurs successfully and according to strategy.
• As a core member of the Medical Sub-Team (MST) on the Global Product Team (GPT), the incumbent will be accountable for establishing the Scientific Communication Platform (SCP) for products in their Therapeutic Area, and ensuring alignment of each product’s overall scientific content/communications strategy reflect the input and requirements of relevant Pfizer Oncology stakeholders (e.g., Medical Strategy, Field Medical, Clinical Development, Scientific Affairs, Research, etc.) and International Oncology Medical Affairs.
• The incumbent will also be responsible for leading engagement with Pfizer U.S. (Medical Platforms) and other enterprise stakeholders as needed to ensure that channel-specific communications strategies and plans are developed and reflect Pfizer Oncology TA teams’ and Field Medical needs. Examples of channel-specific strategies and plans include publications strategy, congress strategy, data amplification and dissemination plans, field content strategy, medical education strategy, etc.
• The incumbent will also act as a strategic advisor to their TA medical team, providing cross-functional guidance and subject matter expertise to foster the creation of effective scientific communication tools, content, and other Scientific Communication deliverables, contributing to the successful development and education of Oncology assets.

ROLE RESPONSIBILITIES

• Accountable for strategic oversight of Therapeutic Area (TA) scientific communication activities and the overarching scientific narrative, ensuring strategic alignment and excellence in delivery.
• Accountable for ensuring strategic input from a broad range of stakeholders (internal and external) is integrated into scientific communications strategic planning to meet the needs of these stakeholders and especially the Oncology Medical TA team.
• Responsible for identifying the need for and establishing the Scientific Communications Platform (SCP) for TA products early in development based on target profile, clinical evidence, disease state / landscape, and aspirational label.
• For later life-cycle assets, determine the need for and enrich the SCP (based on cross-functional input in the MST) with evolving evidence from clinical studies, insights, the Clinical Development Plan and regulatory strategy to ensure teams use accurate, consistent language and referencing aligned with the overarching MST strategy.
• Ensure the product-level SCP is aligned to the broader Therapeutic Area, tumor and/or modality scientific narrative.
• Accountable for ensuring the creation of the holistic global Publications Plan for each asset that accurately reflects the SCP and strategic needs of the Global Medical TA team, to be reviewed at MSTs and endorsed by the GPT. Provide strategic oversight of Pfizer Oncology driven publications in collaboration with Pfizer U.S. (Medical Platforms) and provide visibility to the MST on the progress on overarching publication plan delivery, metrics, and alignment to the SCP.
• Work closely with clinical study teams during data readouts to determine key messages and publication content (aligned to overall publication strategy and SCP).
• Ensure updates to global publication plans occur as needed on a regular basis.
• Accountable for ensuring the creation of a holistic global scientific congress strategy for their TA. This includes ensuring the inclusion of the needs of a wide variety of stakeholders (particularly the Global Medical TA team) into strategic planning, prioritizing areas of interest from the scientific community for inclusion at congress exhibits, prioritizing key scientific messages, ensuring alignment with the SCP, and leading collaboration with Pfizer U.S. (Medical Platforms) on execution activities (e.g., booth design, data amplifica